中华肿瘤杂志
中華腫瘤雜誌
중화종류잡지
CHINESE JOURNAL OF ONCOLOGY
2010年
7期
529-532
,共4页
马飞%廖瑜倩%樊英%王迎红%梁建明%马洁%徐兵河
馬飛%廖瑜倩%樊英%王迎紅%樑建明%馬潔%徐兵河
마비%료유천%번영%왕영홍%량건명%마길%서병하
P糖蛋白%功能%多药耐药%乳腺肿瘤
P糖蛋白%功能%多藥耐藥%乳腺腫瘤
P당단백%공능%다약내약%유선종류
P-glycoprotein%Function%Multidrug resistance%Breast neoplasms
目的 建立人外周血NK细胞P糖蛋白功能检测的方法,分析P糖蛋白功能与乳腺癌患者原发性多药耐药之间的关系.方法 选择经含蒽环类和紫杉类药物联合化疗的初治乳腺癌患者16例,治疗后化疗敏感和耐药者各8例.采集患者外周血标本,分离NK细胞,与荧光物质罗丹明123(Rh123)孵育,应用流式细胞仪检测不同时间点外周血NK细胞内Rh123的荧光强度;以Rh123的荧光强度(F)和相应时间点(t)作图,通过曲线估计回归分析,构建P糖蛋白药泵功能检测的最佳数学模型,计算每例患者相应的外排速率常数;分析化疗敏感组和耐药组患者速率常数的差异,以及以速率常数预测乳腺癌原发性多药耐药的可行性.结果 所有患者的NK细胞在撤离Rh123后60min,基本不再外排Rh123,NK细胞内Rh123的蓄积量、排出量和残留量均与化疗敏感性之间无明显相关性.通过回归分析建立了P糖蛋白功能检测的最佳数学模型F1=F0·e-kt(F1为t时间点的荧光强度,k为外排速率常数),化疗敏感组与耐药组患者外排速率常数差异有统计学意义(P=0.025).以k>3.9为标准,诊断乳腺癌原发性多药耐药,其诊断敏感性为75.0%,特异性为100%.准确率87.5%.结论 外周血NK细胞P糖蛋白药泵外排功能与乳腺癌患者原发性多药耐药密切相关,外排速率常数可能是预测乳腺癌化疗敏感性的理想指标.
目的 建立人外週血NK細胞P糖蛋白功能檢測的方法,分析P糖蛋白功能與乳腺癌患者原髮性多藥耐藥之間的關繫.方法 選擇經含蒽環類和紫杉類藥物聯閤化療的初治乳腺癌患者16例,治療後化療敏感和耐藥者各8例.採集患者外週血標本,分離NK細胞,與熒光物質囉丹明123(Rh123)孵育,應用流式細胞儀檢測不同時間點外週血NK細胞內Rh123的熒光彊度;以Rh123的熒光彊度(F)和相應時間點(t)作圖,通過麯線估計迴歸分析,構建P糖蛋白藥泵功能檢測的最佳數學模型,計算每例患者相應的外排速率常數;分析化療敏感組和耐藥組患者速率常數的差異,以及以速率常數預測乳腺癌原髮性多藥耐藥的可行性.結果 所有患者的NK細胞在撤離Rh123後60min,基本不再外排Rh123,NK細胞內Rh123的蓄積量、排齣量和殘留量均與化療敏感性之間無明顯相關性.通過迴歸分析建立瞭P糖蛋白功能檢測的最佳數學模型F1=F0·e-kt(F1為t時間點的熒光彊度,k為外排速率常數),化療敏感組與耐藥組患者外排速率常數差異有統計學意義(P=0.025).以k>3.9為標準,診斷乳腺癌原髮性多藥耐藥,其診斷敏感性為75.0%,特異性為100%.準確率87.5%.結論 外週血NK細胞P糖蛋白藥泵外排功能與乳腺癌患者原髮性多藥耐藥密切相關,外排速率常數可能是預測乳腺癌化療敏感性的理想指標.
목적 건립인외주혈NK세포P당단백공능검측적방법,분석P당단백공능여유선암환자원발성다약내약지간적관계.방법 선택경함은배류화자삼류약물연합화료적초치유선암환자16례,치료후화료민감화내약자각8례.채집환자외주혈표본,분리NK세포,여형광물질라단명123(Rh123)부육,응용류식세포의검측불동시간점외주혈NK세포내Rh123적형광강도;이Rh123적형광강도(F)화상응시간점(t)작도,통과곡선고계회귀분석,구건P당단백약빙공능검측적최가수학모형,계산매례환자상응적외배속솔상수;분석화료민감조화내약조환자속솔상수적차이,이급이속솔상수예측유선암원발성다약내약적가행성.결과 소유환자적NK세포재철리Rh123후60min,기본불재외배Rh123,NK세포내Rh123적축적량、배출량화잔류량균여화료민감성지간무명현상관성.통과회귀분석건립료P당단백공능검측적최가수학모형F1=F0·e-kt(F1위t시간점적형광강도,k위외배속솔상수),화료민감조여내약조환자외배속솔상수차이유통계학의의(P=0.025).이k>3.9위표준,진단유선암원발성다약내약,기진단민감성위75.0%,특이성위100%.준학솔87.5%.결론 외주혈NK세포P당단백약빙외배공능여유선암환자원발성다약내약밀절상관,외배속솔상수가능시예측유선암화료민감성적이상지표.
Objective To analyze the relationship between P-glycoprotein function in peripheral blood ceils and primary multidrug resistance in breast carcinoma. Methods P-gp function was investigated by flow cytometry in NK cells of 16 breast cancer patients treated with anthracyclines and taxnes. Among all the patients, 8 were in chemotherapy-sensitive group and 8 in chemotherapy-resistant group. P-gp function was determined by rhodamine 123 (Rh123 ) -ejection test. Mathematical model was established by a regression of the fluorescence-time curve. The efflux rate constants of the chemotherapy-sensitive and -resistant groups were compared. Results There was no significant difference of Rh123 accumulation, retaintion or efflux between the two groups. The mathematical model of F1 = F0·e-kt was established. K was the efflux rate constant, which was significantly different between the chemotherapy-sensitive and -resistant groups (P =0.025). When k >3. 9 was used as diagnostic criterium for primary resistance, the sensitivity, specificity and accuracy were 75.0% , 100% and 87.5% , respectively. Conclusion P-glycoprotein function in peripheral blood cells is associated with primary multidrug resistance in breast carcinoma. The efflux rate constant may be a good predictor for chemotherapy sensitivity.